
Brigitte Robertson, MD, shares information on innovative, genetically targeted treatments for alcohol use disorder, aiming to personalize care and improve patient outcomes.
Dr Robertson is the chief medical officer at Adial Pharmaceuticals.
Brigitte Robertson, MD, shares information on innovative, genetically targeted treatments for alcohol use disorder, aiming to personalize care and improve patient outcomes.
Published: May 13th 2025 | Updated: